Increases m arterial pressure and paraventricular nucleus vasopressm release m response to mtracerebroventncular mJections of angrotensm peptides are blunted m mRen2(27) remn transgemc [TG( +)] rats. Intraventrtcular mJections of tachykmm peptides mimic several of the actions of angrotensm peptides, and anglotensm pepttdes evoke substance P release from hypothalamic brain slices The present study assessed whether dtmnnshed substance P release occurs m response to angiotensm peptides m TG(+) rats Systohc blood pressure at 8 to 12 weeks of age averaged 19724 mm Hg (n=20, P<.O5) m TG(+) rats compared with 12324 mm Hg m normotenstve control [TG(-)] rats (n= 18) Body weight was lower m hypertensive than m normotensive rats (305214 versus 344213 g, respectively, P< 05) Brain slices from hypothalamus were perfused at 37°C with oxygenated Krebs' bicarbonate buffer Substance P was measured before (basal) and during perfusion with etther Krebs' buffer (control) or 2 bmol/L angtotensm-( 1-7) or angtotensm II Basal substance P release was 92210 pg/g wet tissue m TG(+) and 98212 pg/g m TG(-) rats (P> 05) and angrotensm II stgmficantly increased substance P release from hypothalamus of TG(-) rats (82% and 70% above control, P< 05) but not TG(+) rats These studies further support the hypothesis that the cardtovascular effects of angtotensm peptrdes are medlated m part by substance P and that this relattonshtp IS blunted m a hypertensive model that results from excess tissue productton of angrotensms (Hypertension. 1997;29[part 2]:510-513.) Key Words l angiotensm peptldes l substance P l hypothalamus l ienm transgemc rat l hypertension R ecent studies mdicate that the mRen2(27) transgemc rat [TG(+)], which expresses htgh levels of angiotensm peptides m the brain,] is less responsive to exogenously applied angiotensm peptides than normotenstve rats. For example, Mortguchi et a12 showed that the pressor response to mtraventricular mJecttons of angiotensm II was absent m TG(+) rats compared with normotenstve Hannover Sprague-Dawley rats Vasopressm release from hypothalamic nuclei m response to either angrotensm-(l-7) or angiotensm II was also dimuushed m the TG( +) rats compared with the normotensive control rats 2 The attenuated responstveness does not appear to be a result of a reduction m the apparent bmdmg densrty of angiotensm II m bram or peripheral tissues.3-7 However, addmonal studies m TG(+) do suggest a downregulation of the receptor signalmg pathways linked to angiotensm II receptors m both brain and pertphery that is not accounted for by reduced numbers of receptors 5.6
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In earlier studies we showed that in brain slices from the hypothalamus, both angiotensm II and angtotensm-(l-7) stimulated the efflux of substance P 8.9 Substance P and other tachykmm peptides exhibit cardiovascular actions consistent with regulation of fluid and electrolyte balance at hypothalamic sites lo-12 These actions include Correspondence to Debra I Dlz, PhD, The Hypertension Center, Bowman Gray School of Medicine, Wake Forest Umverslty, Medtcal Center Blvd, Wmston-Salem, NC 27157-1032 E-mall ddtz@ bgsm edu 0 1997 American Heart Assoclatton, Inc increases m arterial pressure and release of vasopressm after mtraventrtcular or paraventrtcular mJections In addition, mteractions among the effects of angiotensin and tachykmm pepttdes are becoming mcreasmgly apparent We showed that the cardiovascular actions of angtotensm II inJected into the nucleus of the solitary tract are blocked by an antagonist of substance P. l1 Others report that the vasopressm release and hypothalamic pressor actions of tachykmms are mediated by angtotensms 1~4 This study was designed to assess both basal and angiotensm pepttde-sttmulated release of substance P from hypothalanuc slices prepared from TG( +) rats compared with that from normotensive control rats. Our findings suggest that the reduced cardtovascular effects and vasopressm release m TG(+) rats m response to exogenously administered angiotensm pepttdes are assoctated with attenuation of angiotensm peptide-stimulated release of substance P m the hypothalamus as well.
Methods
Male heterozygous mRen2(27) transgemc rats (8 to 12 weeks of age) and age-matched normotenslve control rats both derived from Hannover Sprague-Dawley rats were obtained from the breeding colony of the Hypertension Center at Bowman Gray School of Medicine Rats were genotyped using polymerase chain reactron amphficatron for the presence of the mRen2(27) gene accordmg to previously published methods to dtstmgmsh httermates carrying the mouse remn gene [TG(+)] and those wtthout the gene [TG(-)] 3 Tail-cuff systolic blood pressures were obtained on untrained rats m the week before study by using a Narco Bio-Systems apparatus (Dtvlston of Intemattonal Bromedical, Inc) Rats were housed m an AALAC-approved temperature-and humtdtty-controlled room on a 12 IZhour hghtdark cycle with free access to water and regular rat chow All procedures mvolvmg animals adhere to mstrtutional guidelines and were approved by the Institutional Animal Cdre and Use Committee Rats were decapitated, the brain removed rapidly, and the hypothalamus dissected away from surrounding tissue accordmg to the followmg landmarks on the ventral surface 1 mm rostra1 to the optic chlasm, caudally at the Junction of the median eminence, and laterally withm 1 mm of the interface with the cortex Dorsally, the cortical tissue above the ventricles was removed This tissue block was then sliced mto l-mm shces m two directions and placed mto a chamber filled with 1 0 mL of Krebs' solution containing 20 pmol/L bacitracm (Sigma) and 6 pmol/L dllhlothreltol (Sigma) and bubbled with 95% 02-5% CO2 to a pH of 7 4, as reported previously 9
The tissue m the chamber was perfused with oxygenated Krebs' solution for 16 minutes to allow for eqmhbratlon 9 Subsequently, three 6-minute collections were taken (~2 5 mL volume each) The first collection period was used as an mdex of basal efflux of substance P The second collection period (stimulus period) consisted of continued perfusIon with either buffer only (control) or buffer containing 2 pmol/L of either angiotensm II or angiotensm-( l-7) (Bachem). During the third collection period all tissues were perfused with buffer only for a recovery period At the end of the experiment, the tissue was removed from the chamber, blotted dry, and weighed For substance P measurements, 1 mL of each sample was added to tubes contammg 50 PL of 1 9 mg/mL aprotmm (Sigma) and 6 8 PL of 0 5 mol/L EDTA, lyophihzed, and leconstltuted to a volume of 0 2 mL for assay The samples were measured by radioimmunoassay (INCSTAR Corporation) Values below the detection hmlt were assigned the detection hmlt of 4 pg per tube Cross-reactivity of the antibody with other tachykmm pepttdes (physalaemm, eledolsm), as reported by the manufacturer of the assay kit was less than 0 002% Interassay varlablhty averaged 15% In prellmmary studies, the buffer either alone or containing the mhlbitors, and buffer containing 2 pmol/L anglotensm II or angiotensm-( l-7) was tested for cross-reactivity 01 interference m the substance P assay Values were below the detectlon lmut for each of these determmatlons
Basal release values were defined as the amount of spontaneous release m the first 6-minute period and expressed per gram tissue wet weight and per mdhhter of perfusate Responses ovet time (stimulus and recovery periods) are expressed as percent of basal If basal values and values from subsequent periods were below the detection limit, the data were excluded from analysis Since the percent change from basal could not be determined
Values are reported as mean+SEM Unpaired Student's t tests were used to compare pressure, body weights, and basal release between TG(+) and TG(-) rats Data were evaluated usmg twoway analyses of variance (ANOVA) for between-strain [TG(+) versus TG(-)] comparisons, followed by Mann Whitney tests One-way ANOVA followed by Student-Newman-Keuls post hoc comparisons was used to compare among treatment groups m a given rat strain [Control, angiotensm II, angiotensm-( l-7)] in the stimulus and recovery periods Logarithmic transformation of the data was performed to achieve homogeneity of variance InStat and Prism software were used for these analyses (GraphPad) A value of P< 05 was taken as mchcatlve of a significant difference among means
Results

Comparison of Initial Values in TG( +) and TG(-) Rats
Systolic blood pressure and body weights for the TG( +) and TG(-) animals used m this study are shown m the Table Pressure was slgmficantly higher and body weight lower m TG(+) rats than m the normotenslve controls Basal release of substance P was not different between hypertensive and normotenslve animals when expressed on the basis of tissue weight or concentration m the perfusate (Table) .
Differences in Responses to Angiotensin Peptides in TG(+) and TG(-) Rats
In both groups of rats, values for substance P m the perfusate tended to decline with time to -80% of basal as seen m the control group perfused with buffer only throughout the experiment (see the Figure) In the presence of either anglotensm II (2 pmol/L) or anglotensm-( l-7) (2 /ImoW) during the stimulus period, there was a 70% to 80% increase m substance P efflux above the time control group from the hypothalamic shces of TG(-) rats (F=4 328, P= 036) On the other hand, there was no slgSubstance P Release *Control (n = 5) -+ Ang II (n = 5) * Ang-(l-7) (n = 6) mficant increase m substance P release from hypothalamic slices of the TG(+) rats treated with either anglotensm II or anglotensm-(l-7) (F=l 06, P= 368) Furthermore, the increase in substance P in response to anglotensm II m TG(-) rats was slgmficantly greater than that observed m TG(+) rats (P< 03) There was no statistical difference m the magnitude of the substance P response to anglotensm-(l-7) between hypertensive and normotenslve rats. In both peptlde-treated groups values for substance P declined towards the control group m the recovery period. There were no differences among control and peptldestimulated groups or between TG( +) and TG( -) rats durmg this period.
Discussion
Angiotensm II and anglotensm-( 1-7) both stimulate the efflux of substance P from hypothalamic brain slices of normotenslve TG(-) rats These findings are consistent with our previous studies showing that both anglotensm peptldes at the dose employed here caused an increase m substance P from hypothalamus of Harlan Sprague-Dawley rats.g In contrast, there was no significant increase m substance P durmg stimulation with this same dose of elther of the anglotensm peptldes m the hypothalamic tissue from the TG(+) rats. Previous work by Monguchl et a12 mdlcated that the pressor response and vasopressm release produced by mtraventrlcular admmlstratlon of anglotensm II and the vasopressm release caused by mtraventrlcular anglotensm-( l-7) were attenuated m TG( +) rats Thus, the present study reveals yet another mdlcatlon of decreased responsiveness to exogenously administered anglotensm peptldes m the TG( +) rat.
The mechanism for the attenuation of the anglotensm peptlde-induced responses m the TG( +) rat 1s not known Endogenous levels of anglotensm II and anglotensm-( l-7) are substantially higher m the hypothalamus of TG(+) rats than m normotenslve control rats 1 In spite of the high levels of anglotensm peptides, separate studies suggest that there are no differences m receptor density or affinity m various brain and peripheral areas.3.7 Therefore, downregulation of the receptor itself appears unlikely However, recent studies by Tallant et al,5 and Weiss et a16 indicate that the activation of mosltol phosphate metabolism by anglotensm II 1s diminished in cultures of brain astrocytes or vascular smooth muscle cells from TG(+) rats In our study, basal substance P was not different between hypertensive and normotenslve rats, but there was no slgmficant increase m substance P m the TG( +) rats when the anglotensm peptldes were tested at a single dose Because additional doses were not tested m our study, it cannot be determined whether the reduced response represents a partial or complete receptor desensltlzatlon Further insights can be obtamed, however, from the data of Tallant and colleague@ since a wider dose range (lo-' to 10M6) was used m their studies They reported that the ICso for angiotensm II was roughly the same m cells from both TG( +) and TG( -) rats However, the maximal response was reduced by over 60% Thus, it 1s possible that basal release of substance P reflects the presence of high endogenous peptlde levels m the face of "normal" receptor numbers. The uncoupling of receptor-slgnalmg mechanisms may then account for both the absence of differences m basal release and the failure of the anglotensm peptldes to stimulate the efflux of substance P m TG(+) rats. The somewhat greater mhlbltlon of the anglotensm II response than of that obtained with anglotensm-( l-7) m the TG( +) rats might be accounted for by the fact that the hypothalamic anglotensm II levels are elevated almost lo-fold m the TG(+) rats, whereas the anglotensm-(l-7) levels are only 5-fold higher Alternately, these differences may reflect differences m signal transduction pathways activated by anglotensm II and anglotensm-( l-7) [15] [16] [17] [18] Finally, these studies provide further mformatlon on the possible pathways and transmitters involved m the cardlovascular and fluid balance actions of anglotensm peptldes Recent work by us m the dorsal medulla oblongata of the rat revealed that the acute cardiovascular actions of anglotensm II are mediated by substance P as they are blocked by substance P antagonist 13 Both anglotensm II and anglotensm-( l-7) stimulate the release of vasopressm dltectly from hypothalamrc tissues 2.19 Only anglotensm II causes an accompanymg increase m blood pressure and the effects on pressure and vasopressm release to anglotensm II are reported to be mediated by different mechanisms and/or receptors *,*0-*2 It is tempting to speculate that the increase m substance P might result m the hypothalamic vasopressm-release effects of the two peptides, whereas release of other transmitters may be responsible for the pressor effects of angiotensm II Evidence m support of this concept comes from a report by Unger et a123 who showed that the mechanisms mediating the pressor effects of the substance P and anglotensm II differ In addition, our earlier studies indicated that while anglotensm II increased substance P, dopamme and norepmephrme efflux from hypothalamic slices, anglotensm-( l-7) increased only substance P efflux.9 Central nervous system release of dopamme, serotomn or norepmephrme 1s known to contribute to the pressor effects of anglotensm II 24-27 Dlfferences in the transmitters released m response to the two peptides provides a potential mechanism for the lack of pressor effects of angiotensm-( l-7)
In summary, the TG(+) hypertensive rat provides a model of hyporesponslveness to exogenously admmlstered anglotensm peptldes While the mechanism for the reduced response 1s not yet known, it 1s likely to be the result of the elevated endogenous peptldes and a concomitant desensltlzatlon of the receptor signaling pathways. 
